High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer

Anticancer Res. 2007 Jul-Aug;27(4B):2493-8.

Abstract

Background: In the light of the recently found contribution of matrix metalloproteinases (MMPs) to oral oncogenesis, the correlation of MMP-7 with risk for oral cancer was investigated.

Materials and methods: The MMP-7 -181A/G polymorphism in 159 German and Greek patients with oral squamous cell carcinoma and 120 healthy controls of equivalent gender and ethnicity was studied.

Results: The detected carrier frequency of the high expression G allele was significantly higher in patients compared to controls (74.8% versus 61.7%, p = 0.0257). This significant difference was more pronounced in patients with early stages of cancer and absent in those with advanced stages. A/G heterozygotes have a double relative risk (OR 2.07, 95%, CI 1.17-3.67) of developing early stages of oral cancer than low expression A/A homozygotes.

Conclusion: MMP-7 gene expression is associated with increased risk only for early stages of oral cancer, possibly due to the inhibitory effect of MMP-7 in angiogenesis.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Carcinoma, Squamous Cell / enzymology*
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / pathology
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Matrix Metalloproteinase 7 / biosynthesis*
  • Matrix Metalloproteinase 7 / genetics
  • Middle Aged
  • Mouth Neoplasms / enzymology*
  • Mouth Neoplasms / genetics
  • Mouth Neoplasms / pathology
  • Neoplasm Staging
  • Polymorphism, Single Nucleotide

Substances

  • Matrix Metalloproteinase 7